Ozempic Shows Mental Health Benefits but Poses Risks if Stopped, New Research Warns

Ozempic Shows Mental Health Benefits but Poses Risks if Stopped, New Research Warns

Recent studies from the past week highlight new insights into Ozempic and similar GLP-1 medications for weight loss. Researchers from the University of Eastern Finland, Karolinska Institutet in Stockholm, and Griffith University in Australia analyzed large-scale data and found that semaglutide, the active ingredient in Ozempic, significantly reduces risks of depression, anxiety, and addiction alongside its weight loss effects. According to their work published in The Lancet Psychiatry, users experienced a 44 percent lower risk of depression and a 38 percent drop in anxiety disorders during treatment periods. Psychiatric hospital visits fell by 42 percent, and substance use disorders decreased by 47 percent compared to times without the medication. The team suggests these benefits may stem from lifestyle changes or direct effects on the brain.

Another study from Washington University School of Medicine, reported by Fox News, warns that stopping GLP-1 drugs like Ozempic quickly erodes heart health gains. Continuous use over three years lowered cardiovascular risk by 18 percent through reductions in cholesterol, blood pressure, inflammation, and insulin resistance. However, quitting for six months raised risk by 4 percent, one year by 14 percent, and two years by 22 percent. Restarting the drugs provided partial protection, only 12 percent, indicating some lasting damage from discontinuation. Lead researcher Ziyad Al-Aly described this as metabolic whiplash, with silent reversals in metabolic health that could lead to heart attacks or strokes.

Oprah Winfrey continues to draw attention for her weight loss transformation using GLP-1 medications. The List reports that recent before-and-after photos from events like the 2025 Tony Awards reveal Ozempic neck, a sagging, crepey skin effect under the jaw due to rapid fat loss outpacing skin adjustment. Winfrey has been seen favoring high-necked outfits to camouflage the loose folds, a common side effect among users.

These developments underscore the dual-edged nature of Ozempic for weight management, offering mental and heart benefits during use but posing challenges with side effects and discontinuation.

Thanks for tuning in, listeners, please subscribe, and remember, this episode was brought to you by Quiet Please podcast networks. For more content like this, please go to Quiet Please dot Ai. Come back next week for more.

Some great Deals https://amzn.to/49SJ3Qs

For more check out http://www.quietplease.ai

This content was created in partnership and with the help of Artificial Intelligence AI

Episoder(73)

Ozempic Weight Loss Study Shows 75 Percent Regain Within 15 Months Without Lifestyle Changes

Ozempic Weight Loss Study Shows 75 Percent Regain Within 15 Months Without Lifestyle Changes

A recent analysis from the University of Cambridge, published in eClinicalMedicine, reveals that people stopping Ozempic-like drugs such as semaglutide and tirzepatide retain about twenty-five percent...

18 Mar 2min

GLP-1 Drug Switching Common in First Year, Study Shows Better Long-Term Weight Loss Success

GLP-1 Drug Switching Common in First Year, Study Shows Better Long-Term Weight Loss Success

A new study from UT Southwestern Medical Center, reported by HealthDay News on March 12, reveals that people often switch between GLP-1 weight-loss drugs like Ozempic and Zepbound within the first yea...

14 Mar 2min

Ozempic and Weight Loss Drugs Reshape Health Expectations as Oprah Becomes Center of Celebrity Debate

Ozempic and Weight Loss Drugs Reshape Health Expectations as Oprah Becomes Center of Celebrity Debate

Ozempic and similar weight loss drugs have dominated health headlines again this week, and much of the conversation is circling around how these medications are reshaping expectations about body size,...

7 Mar 4min

GLP One Drugs Transform Weight Loss and Diabetes Treatment as Market Expands to 25 Million Users by 2030

GLP One Drugs Transform Weight Loss and Diabetes Treatment as Market Expands to 25 Million Users by 2030

The landscape of weight loss medications is evolving rapidly. Just this week, Health Canada approved an expanded indication for Ozempic, semaglutide injection, to reduce the risk of major adverse card...

4 Mar 2min

Novo Nordisk Slashes Wegovy and Ozempic Prices Up to 50 Percent Starting January 2027

Novo Nordisk Slashes Wegovy and Ozempic Prices Up to 50 Percent Starting January 2027

The weight loss drug market is undergoing a dramatic transformation this week as Novo Nordisk announced major price cuts for its popular medications Ozempic and Wegovy. Starting January 2027, the Dani...

28 Feb 2min

Novo Nordisk Cuts Ozempic and Wegovy Prices Up to Fifty Percent Starting January 2027

Novo Nordisk Cuts Ozempic and Wegovy Prices Up to Fifty Percent Starting January 2027

Novo Nordisk announced on Tuesday that it plans to cut the list prices of its blockbuster weight-loss and diabetes drugs Ozempic and Wegovy by up to fifty percent starting January first, twenty twenty...

25 Feb 2min

Ozempic MDL Reaches 3000 Cases Over Side Effects While Users Weigh Benefits Against Risks

Ozempic MDL Reaches 3000 Cases Over Side Effects While Users Weigh Benefits Against Risks

Recent developments in the Ozempic multidistrict litigation highlight growing concerns over side effects from the popular weight loss drug. Lawsuit Information Center reports that as of early February...

21 Feb 2min

GLP-1 Weight Loss Drugs Ozempic and Mounjaro Show 11 to 16 Percent Results Despite Side Effects

GLP-1 Weight Loss Drugs Ozempic and Mounjaro Show 11 to 16 Percent Results Despite Side Effects

Recent Cochrane reviews commissioned by the World Health Organization show that blockbuster weight loss drugs like Ozempic deliver substantial results. According to ScienceDaily reporting on February ...

18 Feb 2min

Populært innen Politikk og nyheter

giver-og-gjengen-vg
aftenpodden
forklart
aftenpodden-usa
popradet
stopp-verden
lydartikler-fra-aftenposten
det-store-bildet
rss-gukild-johaug
dine-penger-pengeradet
nokon-ma-ga
fotballpodden-2
hanna-de-heldige
aftenbla-bla
rss-ness
rss-espen-lee-usensurert
rss-penger-polser-og-politikk
rss-dannet-uten-piano
frokostshowet-pa-p5
rss-utenrikskomiteen-med-bogen-og-grasvik